News

INEYE THERAPEUTICS, S. A. has received authorization from INFARMED to conduct the formative usability evaluation of the investigational medical device InEye® PEARL®*. The approval follows a positive assessment by the Portuguese regulatory authorities and ethics committee, confirming compliance with the applicable requirements under Regulation (EU) 2017/745. This important milestone supports the ongoing development of InEye®PEARL® and […]

We are proud to announce that INEYE THERAPEUTICS and ULS Coimbra have received approval for their joint Demonstrator Project under the COMPETE 2030 – Call MPr-2024-9 (SIID – Business R&D – Demonstrators) program.
This project represents a major step forward in validating the InEye® technology for the reduction of dry eye symptoms.

We are pleased to share that members of the Ineye Therapeutics R&D team have co-authored a new peer-reviewed article published in Discover Materials (Springer Nature, 2025), titled “Quality by design & failure mode and effects analysis applied to the eco-friendly synthesis of PCL-co-PEG copolymers.”

INEYE THERAPEUTICS, S.A. has just secured a new investment round totaling €600,000, with continued support from Portugal Ventures and the entry of Insight Venture as a co-investor. This follow-on investment of €250,000 from Portugal Ventures follows an initial investment of €100,000 made in 2023 under the INNOV-ID Call program.

Paula Ferreira, CTO of the start-up INEYE THERAPEUTICS, was one of the winners of the prestigious Women TechEU competition, an initiative by the European Union that supports female leaders of innovative deep-tech start-ups in Europe and Associated Countries.